Epidemiology and Changes in Mortality of Sepsis After the Implementation of Surviving Sepsis Campaign Guidelines

Abstract

Purpose:

To determine the epidemiology and outcome of severe sepsis and septic shock after 9 years of the implementation of the Surviving Sepsis Campaign (SSC) and to build a mortality prediction model.

Methods:

This is a prospective, multicenter, observational study performed during a 5-month period in 2011 in a network of 11 intensive care units (ICUs). We compared our findings with those obtained in the same ICUs in a study conducted in 2002.

Results:

The current cohort included 262 episodes of severe sepsis and/or septic shock, and the 2002 cohort included 324. The prevalence was 14% (95% confidence interval: 12.5-15.7) with no differences to 2002. The population-based incidence was 31 cases/100 000 inhabitants/year. Patients in 2011 had a significantly lower Acute Physiology and Chronic Health Evaluation II (APACHE II; 21.9 ± 6.6 vs 25.5 ± 7.07), Logistic Organ Dysfunction Score (5.6 ± 3.2 vs 6.3 ± 3.6), and Sequential Organ Failure Assessment (SOFA) scores on day 1 (8 ± 3.5 vs 9.6 ± 3.7; P < .01). The main source of infection was intraabdominal (32.5%) although microbiologic isolation was possible in 56.7% of cases. The 2011 cohort had a marked reduction in 48-hour (7% vs 14.8%), ICU (27.2% vs 48.2%), and in-hospital (36.7% vs 54.3%) mortalities. Most relevant factors associated with death were APACHE II score, age, previous immunosuppression and liver insufficiency, alcoholism, nosocomial infection, and Delta SOFA score.

Conclusion:

Although the incidence of sepsis/septic shock remained unchanged during a 10-year period, the implementation of the SSC guidelines resulted in a marked decrease in the overall mortality. The lower severity of patients on ICU admission and the reduced early mortality suggest an improvement in early diagnosis, better initial management, and earlier antibiotic treatment.

Keywords

severe sepsis septic shock organ failure mortality epidemiology Surviving Sepsis Campaign

Get full access to this article

View all access options for this article.

References

Martin

Mannino

Eaton

Moss

. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554.

Martin

. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10(6):701–706.

Angus

Linde-Zwirble

Lidicker

Clermont

Carcillo

Pinsky

. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310.

Iñigo

Sendra

Diaz

Bouza

Sarría-Santamera

. Epidemiología y costes de la sepsis grave en Madrid. Estudio de altas hospitalarias. Med Intensiva. 2006;30(5):197–203.

Villar

Pérez-Méndez

Espinosa

. Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PLoS One. 2009;4(8):e6818.

Walkey

Wiener

. Hospital case volume and outcomes among patients hospitalized with severe sepsis. Am J Respir Crit Care Med. 2014;189(5):548–555.

Vincent

Sakr

Sprung

; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–353.

Brun-Buisson

. The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000;26(supp 1):S64–S74.

Esteban

Frutos-Vivar

Ferguson

. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med. 2007;35(5):1284–1289.

10.

Alberti

Brun-Buisson

Burchardi

. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28(2):108–121.

11.

Dellinger

Carlet

Masur

. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004;30(4):536–555.

12.

Dellinger

Levy

Carlet

. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296–327.

13.

Dellinger

Levy

Rhodes

. Surviving Sepsis Campaign guidelines committee including the pediatric subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.

14.

Rhodes

Evans

Alhazzani

. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377. doi:10.1007/s00134-017-4683-6.

15.

Dombrovskiy

Martin

Sunderram

Paz

. Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. Crit Care Med. 2005;33(11):2555–2562.

16.

Ferrer

Artigas

Levy

. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA. 2008;299(19):2294–2303.

17.

Levy

Dellinger

Townsend

. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38(2):367–74.

18.

Castellanos-Ortega

Suberviola

Garcia-Astudillo

. Impact of the Surviving Ssepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med. 2010;38(4):1036–1043.

19.

Ranieri

Thompson

Barie

. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055–2064.

20.

Gaieski

Edwards

Kallan

Carr

. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–1174.

21.

Stevenson

Rubenstein

Radin

Wiener

Walkey

. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med. 2014;42(3):625–631.

22.

Ayala-Ramírez

Domínguez-Berjón

Esteban-Vasallo

. Trends in hospitalizations of patients with sepsis and factors associated with inpatient mortality in the region of Madrid, 2003-2011. Eur J Clin Microbiol Infect Dis. 2014;33(3):411–421.

23.

Kaukonen

Bailey

Suzuki

Pilcher

Bellomo

. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311(13):1308–1316.

24.

ProCESS Investigators, Yealy

Kellum

. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–1693.

25.

The ARISE Investigators and the ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–1506.

26.

Mouncey

Osborn

Power

. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–1311.

27.

Levy

Artigas

Phillips

. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–924.

28.

Blanco

Muriel-Bombín

Sagredo

. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care. 2008;12(6):R158.

29.

Bernard

Vincent

Laterre

. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699–709.

30.

Annane

Sébille

Charpentier

. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862–871.

31.

Singer

Deutschman

Seymour

. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis – 3). JAMA. 2016;315(8):801–810.

32.

Levy

Fink

Marshall

. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–1256.

33.

Garner

Jarvis

Emori

Horan

Hughes

. CDC definitions for nosocomial infections. Am J Infect Control. 1988;16(3):128–140.

34.

McCabe

Jackson

. Gram negative bacteremia: etiology and ecology. Arch Intern Med. 1962;110(6):847–852.

35.

Knaus

Draper

Wagner

Zimmerman

. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829.

36.

Le Gall

Klar

Lemeshow

. The Logistic Organ Dysfunction System. A new way to assess organ dysfunction in the intensive care unit. ICU scoring group. JAMA. 1996;276(10):802–810.

37.

Vincent

Moreno

Takala

. The SOFA (Sepsis Related Organ Failure Assessment) score to describe organ/dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–710.

38.

Bernard

Artigas

Brigham

. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 pt 1):818–824.

39.

Instituto Nacional de Estadística. Censo de Población y Viviendas. 2011. www.ine.es. Accessed May 26, 2017.

40.

Danai

Martin

. Epidemiology of sepsis: recent advances. Curr Infect Dis Rep. 2005;7(5):329–334.

41.

Jones

Trzechiak

Kline

. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009;37(5):1649–1654.

42.

Lopes Ferrerira

Peres Bota

Bross

Mélot

Vincent

. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754–1758.

43.

Mayr

Yende

Angus

. Epidemiology of severe sepsis. Virulence. 2014;5(1):4–11.

44.

Azkárate

Sebastián

Cabarcos

Choperena

Pascal

Salas

. Registro observacional y prospectivo de sepsis grave/shock séptico en un hospital terciario de la provincia de Guipúzcoa. Med Intensiva. 2012;36(4):250–256.

45.

Annane

Aegerter

Jars-Guincestre

Guidet

; CUB-Réa Network. Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med. 2003;168(2):165–172.

46.

Brun-Buisson

Meshaka

Pinton

Vallet

; EPISEPSIS Study Group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004;30(4):580–588.

47.

Vincent

Rello

Marshall

. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329.

48.

Danai

Sinha

Moss

Haber

Martin

. Seasonal variation in the epidemiology of sepsis. Crit Care Med. 2007;35(2):410–415.

49.

Herrán-Monge

Muriel-Bombín

García-García

. Mortality reduction and long-term compliance with Surviving Sepsis Campaign: a nationwide multicenter study. Shock. 2016;45(6):598–606.

50.

Sánchez

Ferrer

Suarez

. Declining mortality due to severe sepsis and septic shock in Spanish intensive care units: a two-cohort study in 2005 and 2011. Med Intensiva. 2017;41(1):28–37.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.26 MB